Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5(NULL)-A20

We previously developed a refined, tumor-selective adenovirus, Ad5(NULL)-A20, harboring tropism ablating mutations in each major capsid protein, to ablate all native means of infection. We incorporated a 20-mer peptide (A20) in the fiber knob for selective infection via αvβ6 integrin, a marker of ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, James A., Marlow, Gareth, Uusi-Kerttula, Hanni K., Seaton, Gillian, Piggott, Luke, Badder, Luned M., Clarkson, Richard W. E., Chester, John D., Parker, Alan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151668/
https://www.ncbi.nlm.nih.gov/pubmed/34066836
http://dx.doi.org/10.3390/v13050864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151668/
https://www.ncbi.nlm.nih.gov/pubmed/34066836
http://dx.doi.org/10.3390/v13050864

Ejemplares similares